• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Roche Receives CE Mark For AI-Enabled Glucose Monitoring

    GLOBENEWSWIRE

    Trinity Biotech Launches Continuous Glucose Monitoring Microsite

    GLOBENEWSWIRE

    Enforcement Report - Week of May 31, 2023

    FDA

    Fresenius Kabi`s Generic Testosterone Receives Approval In US

    FDA

    Efruxifermin Associated With Improved Glucose Metabolism in Patients

    FIRSTWORDPHARMA

    Rezolute Added to Russell Microcap® Index

    GLOBENEWSWIRE

    ADA: Senseonics shows off accuracy for 180-day glucose sensor

    FIERCEBIOTECH

    Centre issues guidelines for management of black fungus in kids below 18

    ECONOMIC TIMES

    Intl Medication Sys`s Generic Dextrose API Receives Approval In US

    FDA

    Baxter Announces U.S. FDA Approval of Clinimix and Clinimix E

    PRESS RELEASE

     Baxter Announces USFDA Approval of Clinimix and Clinimix E

    BUSINESSWIRE

    Fresenius Kabi USA`s Generic Dextrose: Sodium Chloride Receives Approval In US

    FDA

    Fresenius Kabi USA`s Generic Dextrose: Sodium Chloride Receives Approval In US

    FDA

    Fresenius Kabi USA`s Generic Dextrose: Sodium Chloride Receives Approval In US

    FDA

    Fresenius Kabi USA`s Generic Dextrose Potassium Chloride Receives Approval In US

    FDA

    Fresenius Kabi`s Generic Dextrose ; Sodium Chloride Receives Approval in US

    FDA

    Fresenius Kabi`s Generic Dextrose and Sodium Chloride Receives Approval in US

    FDA

    Enforcement Report - Week of November 14, 2018

    FDA

    NovioSense Announces Positive Phase 2 Clinical Trial Results

    BUSINESSWIRE

    Enforcement Report - Week of October 3, 2018

    FDA

    Fresenius Kabi USA’s Generic Dextrose Injectable Receives Approval In The US

    FDA

    Advanced Pharma, Inc. D/B/A Avella of Houston Issues Voluntary Nationwide Recall

    FDA

    Top EU court bars Dextrose tablet maker`s glucose health claims

    REUTERS

    Hospira recalls injected dextrose for infants

    FIERCE PHARMA

    Anvisa suspends batch of generic Glucose 10%

    ANVISA

    Eli Lilly updates Trulicity label to include use in combo with basal insulin

    PHARMABIZ

    Artificial insulin-producing cells may help manage diabetes

    FINANCIAL EXPRESS

    FDA Approves Sanofi`s Combination Diabetes Drug

    DDDMAG

    Fresenius`s Generic Dextrose Approved In US

    FDA

    US FDA Enforcement Report- 1/June/2016

    FDA

    B. Braun Medical Issues Voluntary Nationwide Recall of Lot J5J706, 5% Dextrose Inj USP

    FDA

    Aurobindo Pharma gets FDA nod bacterial infection injection Dextrose

    IIFL

    Expanding the Analytical Toolbox for Identity Testing of Pharmaceutical Ingredients: Spectroscopic Screening of Dextrose Using Portable Raman and Near Infrared

    PHARMA-EXCIPIENTS

    Baxter initiates Voluntary Nationwide Recall of Select Lots of IV Solutions Due to the Potential for Leaking Containers and Particulate Matter

    FDA

    Boston` sugardown in clinical trials reduces glucose, fructose and insulin

    CPHI ONLINE

    Brief periods of standing, walking tied to better blood sugar

    REUTERS

    Recall: Baxter`s Clinimix (2015-06-19)

    HEALTHY CANADIANS

    Fresenius Kabi USA, LLC initiates Class II recall of Kabiven Due to Label Error on Declared Strength

    FDA

    Hospira Initiates Class I Recall of Magnesium Sulfate in 5% Dextrose Injection

    FDA

    Drug shortages become issue in Teva and Mylan hook-up

    FIERCE PHARMA MANUFACTURING

    Baxter Initiates Voluntary Recall Due to the Presence of Particulate Matter

    FDA

    Baxter Healthcare Corp, Ongoing Class II recall of Clinimix E 5/20 sulfite-free (5% amino-acid with electrolytes in 20% dextrose with calcium) Injection, 2000 mL in Dual Chamber Container, Rx Only, Baxter Healthcare Corporation, Deerfield, IL --- Product code 2B7722, NDC 0338-1125-04 because of Lack of Assurance of Sterility; increased complaints received for leaks

    FDA

    Baxter Healthcare Corp., Ongoing Class II recall of 5% Dextrose Injection, USP, 1000mL in VIAFLEX Plastic Container, Rx only, Manufactured by Baxter Healthcare Corp., North Cove, North Carolina Facility Highway 221 North, Marion, NC 28752 for Baxter Healthcare Corporation, One Baxter Parkway, Deerfield, IL 60015. NDC 0338-0017-04 because of Lack of Assurance of Sterility. Complaints were receive of missing closures and/or leaks which may compromise product sterility.

    FDA

    Hospira Inc., Ongoing Class II recall of 5% DEXTROSE Injection, USP, 250 mL ADD-Vantage Unit bag (NDC 0409-7100-04), UPC (01)003040971000040, packaged in 24 bags per case pack (NDC 0409-7100-02), UPC (01)30304097100027(30)01, Rx only, Hospira, Inc., Lake Forest, IL 60045. because of Lack of Assurance of Sterility: there is a potential for solution to leak at the administrative port of the primary container.

    FDA

    Dextrose 5% INJ 5 g /100 mL USP (2015-03-04)

    HEALTHY CANADIANS

    0.9% Sodium Chloride Injection USP and 5% Dextrose Injection USP - Recalled Lot Due to the Potential for Leakage of the Parenteral Solution Bag

    HEALTHY CANADIANS

    New Study Finds Toddler Foods Have High Salt And Sugar

    REUTERS

    Baxter Healthcare Corp., Ongoing Class II recall of Clinimix E 4.25/10 sulfite-free (4.25% Amino Acid with Electrolytes in 10% Dextrose with Calcium) Injections, in CLARITY Dual Chamber Container, Baxter Healthcare Corporation, Deerfield, IL NDC 0338-1115-04 because of Lack of Assurance of Sterility; leaks were observed from the bag seam and port seal

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.